title: Diminution in adenine nucleotide hydrolysis by platelets and serum from rats submitted to Walker 256 tumour.
abstract: Extracellular adenine nucleotide hydrolysis in the circulation is mediated by the action of an NTPDase (CD39, apyrase) and of a 5'-nucleotidase (CD73), presenting as a final product, adenosine. Among other properties described for adenine nucleotides, an anti-cancer activity is suggested, since ATP is considered a cytotoxic molecule in several tumour cell systems. Conversely, some studies demonstrate that adenosine presents a tumour-promoting activity. In this study, we evaluated the pattern of adenine nucleotide hydrolysis by serum and platelets from rats submitted to the Walker 256 tumour model. Extracellular adenine nucleotide hydrolysis by blood serum and platelets obtained from rats at, 6, 10 and 15 days after the subcutaneous Walker 256 tumour inoculation, was evaluated. Our results demonstrate a significant reduction in ATP, ADP and AMP hydrolysis in blood serum at 6, 10 and 15 days after tumour induction. In platelets, a significant reduction in ATP and AMP hydrolysis was observed at 10 and 15 days after tumour induction, while an inhibition of ADP hydrolysis was observed at all times studied. Based on these results, it is possible to suggest a physiologic protection mechanism against the tumoral process in circulation. The inhibition in nucleotide hydrolysis observed probably maintains ATP levels elevated (cytotoxic compound) and, at the same time, reduces the adenosine production (tumour-promoting molecule) in the circulation.
authors.affiliation: Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
authors.forename: Andréia
authors.initials: A
authors.lastname: Buffon
authors.forename: Vanessa B
authors.initials: VB
authors.lastname: Ribeiro
authors.forename: Alessandra S
authors.initials: AS
authors.lastname: Schanoski
authors.forename: João J F
authors.initials: JJ
authors.lastname: Sarkis
mesh_terms: D000227:Adenine Nucleotides / Q000037:antagonists & inhibitors / Q000378:metabolism*; D000818:Animals; D001792:Blood Platelets / Q000201:enzymology / Q000378:metabolism*; D002279:Carcinoma 256, Walker / Q000097:blood* / Q000201:enzymology; D006868:Hydrolysis; D011755:Pyrophosphatases / Q000097:blood; D051381:Rats; D044967:Serum / Q000201:enzymology / Q000378:metabolism*; D014407:Tumor Cells, Cultured
chemical_list: D000227:Adenine Nucleotides; D011755:Pyrophosphatases